Category - march-in rights

autm Bayh-Dole Act Books Business Capitol Hill Congress Government Guest Contributor Guest Contributors innovation intellectual property IPWatchdog Articles Knowledge Ecology International Legislation Licensing march-in rights National Institute of Standards and Technology patent Patents pharmaceuticals technology Technology & Innovation

Knowledge Ecology International Letter Misleads on March-In Rights

“To say, as KEI and different critics do, that the general public is paying for the analysis and improvement of medicine utilizing taxpayer dollars, is at...

#breakthepatent Access AIDS and Knowledge Bayh-Dole Act bio Books Business Centers for Disease Control and Prevention drug pricing Food and Drug Administration Generics Gilead Sciences Government HIV Initiative for Medicines IP News IPWatchdog Articles march-in rights National Institutes of Health orange book Patents pharmaceuticals PhRMA PrEP Technology & Innovation Truvada

Examining the Truvada #BreakThePatent Debate: Gilead Responds

We consider that one of many biggest limitations to Truvada for PrEP entry in the present day is restricted consciousness of Truvada for PrEP’s position in HIV...